SCHEMBL7367544

SCHEMBL7367544

CC(C)(C)OC(=O)N1CCC(CCN2CC(=O)N(CC(=O)O)CC2=O)CC1

nearest known ligand 0.46

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.46
PKM P14618 1/20 0.46
GPR119 Q8TDV5 12/20 0.44
FAAH O00519 1/20 0.44
FPR2 P25090 1/20 0.41
MAPT P10636 1/20 0.41
THRB P10828 1/20 0.41
PTPN2 P17706 1/20 0.41
PTPN1 P18031 1/20 0.41
PTPN6 P29350 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7957340 0.89 KDM4E (0.46) KDM4EPKMGPR119FAAHFPR2
SCHEMBL7277084 0.85 FAAH (0.46) KDM4EPKMGPR119FAAHMAPT
SCHEMBL8892804 0.80 KDM4E (0.55) KDM4EPKMGPR119FAAH
Hydrochloric Acid SCHEMBL8669970 0.80 TP53 (0.45) KDM4EPKMGPR119MAPTTHRB
SCHEMBL28437919 0.79 NR1H2 (0.43) KDM4EPKMGPR119FAAHMAPT
SCHEMBL7367257 0.79 KDM4E (0.47) KDM4EPKMGPR119FAAHMAPT
SCHEMBL9031543 0.79 TP53 (0.46) KDM4EPKMGPR119MAPTTHRB
SCHEMBL7274902 0.79 ACE (0.49) KDM4EPKMGPR119FAAHFPR2
SCHEMBL7274867 0.78 KDM4E (0.45) KDM4EPKMGPR119FAAHFPR2
SCHEMBL7395465 0.78 GPR119 (0.48) KDM4EPKMGPR119FAAHMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6211183-B1 PIPERAZINE DERIVATIVE ANTICOAGULANTS; ANTIISCHEMIC AGENTS; CARDIOVASCULAR DISORDERS COR THERAPEUTICS, INC. 2001-04-03 US disclosed
EP-0975625-A1 SELECTIVE FACTOR Xa INHIBITORS COR THERAPEUTICS, INC. (US) 2000-02-02 EP disclosed
WO-1998046591-A1 SELECTIVE FACTOR Xa INHIBITORS COR THERAPEUTICS, INC. (US) 1998-10-22 WO disclosed